Loading…
Glow Nest Beauty was cited for introducing unapproved and misbranded injectable botulinum toxin (Botox) products into interstate commerce through their website, violating sections 301(a), 301(d), 301(k), 503(b), and 505(a) of the Federal Food, Drug, and Cosmetic Act. The company failed to obtain FDA approval for these new drug products prior to marketing them to U.S. consumers. The FDA emphasized that unapproved injectable drugs pose serious health risks including contamination, counterfeit products, inconsistent active ingredient amounts, and potentially life-threatening conditions such as sepsis, and requested immediate cessation of sales.